Therapeuticsmd Inc (TXMD)

Nov 12, 2024, 4:05 PM EST - 2 months ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Aug 26, 2024, 7:36 AM EDT - 5 months ago

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

Aug 12, 2024, 4:05 PM EDT - 5 months ago

TherapeuticsMD Announces Second Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 9 months ago

TherapeuticsMD Announces First Quarter 2024 Financial Results

Mar 29, 2024, 4:00 PM EDT - 10 months ago

TherapeuticsMD Announces Full Year 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 1 year ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results

May 23, 2023, 9:00 AM EDT - 1 year ago

TherapeuticsMD: From Fallen And Forgotten To Cash Cow

May 15, 2023, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces First Quarter 2023 Financial Results

Apr 7, 2023, 4:01 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Jan 3, 2023, 6:50 AM EST - 2 years ago

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

Dec 4, 2022, 6:00 PM EST - 2 years ago

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

Nov 14, 2022, 4:05 PM EST - 2 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results

Oct 31, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Additional $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces $7 Million Private Placement

Sep 12, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

Aug 15, 2022, 9:46 AM EDT - 2 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call Transcript

Aug 15, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 8, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

Aug 1, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Jul 13, 2022, 9:59 AM EDT - 2 years ago

Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 8:25 AM EDT - 2 years ago

TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Expiration of Tender Offer

Jul 6, 2022, 6:09 AM EDT - 2 years ago

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

Jun 21, 2022, 12:01 PM EDT - 2 years ago

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

WEBR

Jun 16, 2022, 2:43 PM EDT - 2 years ago

TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback

Jun 13, 2022, 10:49 AM EDT - 2 years ago

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

BEEM

Jun 6, 2022, 4:05 PM EDT - 2 years ago

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

May 31, 2022, 7:34 PM EDT - 2 years ago

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

May 31, 2022, 1:57 PM EDT - 2 years ago

Here is why TherapeuticsMD jumped 300%

May 31, 2022, 10:12 AM EDT - 2 years ago

Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 6:00 AM EDT - 2 years ago

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

May 20, 2022, 10:54 AM EDT - 2 years ago

Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 9:43 AM EDT - 2 years ago

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

May 16, 2022, 8:07 PM EDT - 2 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript

May 16, 2022, 4:05 PM EDT - 2 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results

May 10, 2022, 4:05 PM EDT - 2 years ago

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

Apr 14, 2022, 4:15 PM EDT - 3 years ago

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

GDRX

Mar 14, 2022, 8:39 AM EDT - 3 years ago

TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business

Mar 10, 2022, 10:35 AM EST - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd On Q4 2021 Results - Earnings Call Transcript

Mar 10, 2022, 6:50 AM EST - 3 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 7, 2022, 9:38 AM EST - 3 years ago

Why TherapeuticsMD Shares Are Soaring Today

Mar 7, 2022, 7:57 AM EST - 3 years ago

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

Mar 7, 2022, 7:40 AM EST - 3 years ago

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

GDRX

Mar 1, 2022, 4:30 PM EST - 3 years ago

TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022

Jan 4, 2022, 6:20 AM EST - 3 years ago

FDA Approves TherapeuticsMD's Low Dose Bijuva